So glad to discover your thread Master Yoda : ) I used

New Post Public Reply Private Reply Replies (1) Message Board
Byron Mophat

So glad to discover your thread Master Yoda : )

I used to read you with delight on the other board, before the "apocalypse", and always admired your well articulated musings. You still manage to rise above the usual merry-go-round afflicting too many shareholders. Your posts offer substance and a refreshing perspective with, as far as I can tell, a tiny glimmer of hope.

Sifting through the nuggets of information you provided over time leads me to think that patience might eventually pay off. Lets hope that it won't be seven years - like that company you mentioned that had their lock lifted. Unfortunately, we can't afford to wait this long. With all the changes occurring in the marijuana sphere, new portable vaporizing devices are being developed. It won't be long before another smokeless product lands on the market. Time is of the essence and it may be the wake up call that is needed with SFIO. Patience alone won't do it. Recriminations either. Action is what is required to avoid missing this very lucrative boat.

The process of trading certificates for new ones, as described in one of your posts, can be done. It's a very sensible option. It would get us on fresh footing, ready for action.

Hiring pronto the brilliant team of lawyers you mentioned earlier - i.e. the guys who successfully had a lock lifted - would radically change our odds.

Pursuing the granting of a US Patent with renewed vigour is also essential. According to Ballbag, who kindly replied in details over there to one of my questions, the US Patent process would require 3 years and $10,000. That money can be found once we are unlocked.

How can we get the ball rolling? (Someone suggested a class action... I don't know anything about such a course of action. Do you?) The last echoes we heard from our management were so underwhelming. What alternative(s) do we have?

SFIO used to be described as a no brainer. Isn't it time to get our brains together?

Smokefree Innotec In (SFIO) Stock Research Links

SFIO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Halozyme's Upcoming Investment Presentation at Healthcare Conference

Updated Category News Views 280

Halozyme's Participation in Major Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) is set to showcase its advancements at an important healthcare conference. Dr. Helen Torley, the president and CEO, will present and engage in investor meetings, highlighting the company's innovative approaches in the biopharmaceutical sector. Details of the Presentation The...

Continue Reading
Emerging Markets Surge Ahead with Historic Bond Sales Strategy

Updated Category News Views 241

Emerging Markets Adjust with Record Bond Sales Amid economic uncertainty, borrowers in developing regions are intensifying their efforts to navigate potential market turbulence, particularly due to significant fluctuations influenced by US economic conditions. Authorities and businesses have proactively begun securing funds through bond sales, reflecting a strategic move...

Continue Reading
Multi Ways Holdings Reflects on Fiscal Year 2024 Performance

Updated Category News Views 167

Multi Ways Holdings Limited Reports on Financial Results Multi Ways Holdings Limited (NYSE American: MWG), a prominent provider of heavy construction equipment, has recently shared its financial outcomes for the fiscal year 2024. With a focus on innovation and customer satisfaction in Singapore and neighboring regions, the company continues to adapt to the dynamic market...

Continue Reading
Neurocrine Adjusts Course Following Luvadaxistat Study Setback

Updated Category News Views 117

Neurocrine Biosciences Shifts Strategy After Luvadaxistat Trial Neurocrine Biosciences Inc. (NASDAQ: NBIX) has made revisions to its strategic approach following the outcomes of the ERUDITE phase two clinical trial involving luvadaxistat (NBI-1065844). This investigational treatment aimed at addressing cognitive impairment in schizophrenia did not achieve its primary...

Continue Reading
Rinnai America Leads Coalition Against DOE Water Heater Rule

Updated Category News Views 294

Rinnai America Takes Action Against DOE Regulations Rinnai America Corporation, a prominent manufacturer of noncondensing tankless water heaters, has joined forces with 21 state attorneys general and various business groups to challenge the recent final rule issued by the U.S. Department of Energy (DOE) concerning consumer tankless water heaters. This action follows a...

Continue Reading